Abstract-The comparative effectiveness of Ca-DTPA and Zn-DTPA in removing internally deposited 239pu,241Am and 242Cm was tested in the rat. The radionuclides were administered in a citrate solution and treatment with three chelate injections (I mmol· kg-1 • d-1) was begun 6 days Iater, No essential differences were observed between the two chelates tested. The data indicate that the removal ofthe isotopes from the liver cannot be a suitable criterion for the effectivenessoftreatment in other soft tissue organs. The liver isotope contentwasreduced to 10% ofthe controls, whereas the content of other organs, including bone, was never reduced to less than 40 % of the control, In Iiver and lung, the response to treatment was different for 241Am and 242Cm as compared to 239pu. There was no such difference as far as other organs are concerned.
INTRODUCTION
TEE CALCIUM chelate of diethylenetriarninepentaacetate (Ca-DTPA) is commonly used for treatment of internal contamination with transuranium elements. However, there is still some reluctance to use Ca-DTPA, because of the toxici ty of chelates observed in animals Cl -5) and following administration of ethylenediaminetetraacetate in man. (6) I t has been assumed that the toxic side effects might be due to the interaction of chelating agents with trace metals, since their che1ates possess considerably higher stability constants than the corresponding calcium chelates'f that are used for therapy. This assumption is supported by an enhanced excretion of these metals; especially of Mn and Zn,(7-9) after chelate administration. Therefore, by injection of the Zn-chelate instead of the Ca-chelate the toxicity of DTPA should be reduced. This was indeed proved for. the Iethal and toxic effects of Zn-diethylenetriaminepentaacetate (Zn-DTPA). (3.4.10-14) Thus, similar effectiveness of Ca-and Zn-DTPA in removing incorporated radionuclides would mean a higher therapeutic index of Zn-DTPA.
First results with 239pU, (15) 91y and 144Ce(16) indicated a higher effectiveness of Ca-DTPl".. in removing these elements from the rat, as compared to Zn-DTPA. However, in recent studies with 147Pm,(17) 238pu (18) and 239pu(19) an equal efficacy of Ca-and Zn-DTPA was found, at least für higher dosages. In the present study the comparative effectiveness of Ca-DTPA and Zn-DTPA on the removal of 241Am and 242Cm is evaluated; in addition, further data on 239pU are given.
METHODS
Female albino rats of the Heiligenberg strain, weighing 180-200 g, were injected intravenously with 0.1-0.3 ",Ci of 239pu, 241Am, or 242Cm, dissolved in 0.25 ml of a 1 %sodium citrate solution, The animals had free access to food (Standard Pellets) and water. In the first experiment, groups of 20 rats were sacrificed at värious time Intervals up to the 10th week after administration of the isotope; they received no therapy at all. In further experiments, Ca-DTPA or Zn-DTPA was administered intraperitoneally on the 6th, 8th and 11th day after isotope injection at a dosage of 1 mmoleJkg of body weight per day. Control animals received 0.9 % NaCl. The animals were killed by desanguination on the 13th day after the isotopes had been administered. Using the same treatment schedule, in one experiment with 239pu, sacrifice was postponed until the 19th day. An additional group of untreated animals was always sacrificed on the first day of treatment (6th day),
The isotopes were maintained in stock rapidly removed from the Iiver, the 239pu burden of this organ becomes relatively higher in later observation periods. The deposition in kidneys, lung and ovaries is virtually Identical for all nuc1ides. The 241Am_ and 242Cm-content of the thyroid is slightly higher than that of 239pu. The treatment schedule is indicated in Fig. 1 , the effect of the two chelates tested on the removal of 239pu, 241Am and 242Cm is presented in Tab1e 1. In Table 2 , these values are expressed as a percentage of the corresponding controls on the 13th day. The results of the experiment, in which the sacrifice was delayed to the 19th day, are given in Table 3 .
The chelate administration results in a statistically significant diminution of the organ content of isotopes as cornpared to the control animals, with the few exceptions indicated in Table 1 . There are no statistically significant differences between the effectiveness of Ca-DTPA and Zn-DTPA, except for the two cases indicated in Table 1 . With the exception ofthe liver, the mobilized fraction depends neither solutions of 3 N HNO s, with a concentration of 50, 76 and 200 p,Cifml for 239pu, 241Arn and 242Cm, respectively. The radiochemical purity amounted to 95 %for 239PU and 98 %for 241Am and 242Cm. The citrate injection solutions were prepared according to T AYLOR. (20) The pH, adjusted between 6.9 and 7.1, regularly rises to values of about 8 when the injection solution is allowed to stand overnight. We performed an auxiliary experiment on rats using the above mentioned procedure and varying the pH of the injection solution between 2.5 and 9.0. This did not infl.uence the distribution pattern of 239pu, 241Arn or 242Cm to a statistically significant degree. (21) Since aliquots of the injection solution were always counted together with the tissue samples, no correction for radioactive decay was necessary in the case of 242Cm.
The chelates tested were Na 3(Ca-DTPA] and Nas[Zn-DTPA], which were prepared from HsDTPA, NaOH and CaC1 2 or ZnO. The concentration of the chelate in solution was 200 p,illolefml, the pH-value was adjusted to 7.4.
Radioactivity of the organs was assayed by alpha liquid scintillation counting using a method described elsewhere, (22) Small organs were analyzed as a whole. The skeletal content was calculated by multiplying by 10 the activity of two femurs. The variation of the activity concentration within the liver was low; therefore, three 400-mg pieces were analyzed .~~t he liver and the total content was calculated by appropriate multiplication by the weight factor.
RESULTS
The retention up to 2 months of 239pu, 241Am and 242Cm in bone and liver of the untreated animals is shown in Fig. 1 , additional control values are listed in Tables 1  and 3 .
With all three radionuclides, the skeletal burden remains nearly constant, while there is a rapid decline of the liver burden and an increasing accumulation in the spleen. The initial 239pu retention by skeleton, spleen and adrenals exceeds by a factor of 2-3 that of 241Am and 242Cm, while the initial 239pu burden of the liver amounts only to about one-third of the corresponding values for 241Am and 242Cm. Since, however, 241Arn and 242Cm are more t Statistically significant differences between Ca-DTPA and Zn-DTPA. § No statistical1y significant differences between treated and contro1 anima1s (13th day). (26) , (26) on the organ nor on the element. Markedly more activity, however, can be removed from the liver, its response to treatment being higher for 241Am and 242Cm than for 239PU. The lung is the only organ from which 239PU is removed to a higher degree than 241Am and 242Cm. A comparison of the values in Table 1 with those in Fig. 1 shows that following DTPAtreatment the 241Am_ and 242Cm-content of the liver on the 13th day is virtually identical with values reached in control animals on the 60th day. The same holds for 241Am in the skeleton, whereas the 242Cm-content of the skeleton as weIl as the 239Pu-content of both organs are lower in treated animals.
The results after delayed sectioning (Table 3 ) indicate that Ca-DTPA exerts an action on the skeletal 23 9pU sustained over several days, whereas both chelates have no such influence on the other organs. It should be noted that the variation between the animals treated with Ca-DTPA is rather low, although there are only 3 animals in this group.
DISCUSSION
The aim of the present study was to make a preliminary evaluation of the effectiveness of Zn-DTPA, as compared to Ca-DTPA, in removing internally deposited transuranium elements, In this respect there was c1ear evidence that Zn-DTPA equaIled Ca-DTPA under the conditions of our experiments. The retention values given in Fig. 1 indicate that the isotopes were injected in "essentially monomeric" form. (20) This is of considerable importance since the effectiveness of the chelating agents depends on the chemical form of the injected isotope. (6) At the time of the first chelate injection the skeletal deposition of all three isotopes was almost completed. On the other hand, there was still a rapid natural dec1ine of the liver activity during the administration of the ehelates. Both chelates possibly eliminated that isotope fraction which, even under normal conditions, would have been removed from the liver with a relatively short half time. Though, in our experiments, the final results of chelation therapy in the liver did not seem to be remarkably better than those of natural excretion up to two months, they suggest a considerable reduction of the radiation dose delivered to the organ during the early phase of deposition.
As far as the skeleton is concerned, the different behavior of 24:lAm and 242Cm should be noted:There was a steady increase in the skeletal 242Cm, whereas the 241Am in bone tended to decreasing values after the 30th day. Thus, chelation therapy gave better results for 242Cm than für 241Am when compared to the control values reached in the skeleton at later observation times. Considering the absolute amount of activity remaining in one organ after treatment, 239pu in bone proved to be the most difficult problem for chelation therapy.
Evidently, our chelate doses exceed by a factor of about 15 those which would be used for human therapy; extrapolation to lower doses should be made very carefully. Furthermore, some differences between Ca-DTPA and Zn-DTPA have been reported'U" in the prompt treatment of 238pu incorporation and we have also observed that at very early stages of internal 241Am contamination high doses of Zn-DTPA are less effective than equal doses of Ca-DTPA. (21) No differences, however, were found in the delayed treatment of 238pu incorporation by multiple chelate injections. (18) In rats, even the application of 3 doses of 2 rnrnol Ca-DTPA . kg-1 . d-1 caused only slight toxic reactions of the blood picture and of the renal functions. (4) I t seems, therefore, improbable that our results were affected by toxic side effects of the chelates.
A sustained action of Ca-DTPA has been shown for 239PU (23) as well as for 241Am.(21·24) The results which are reported in Table 3 for 239pu indicate, however, that our values are not markedly changed if sacrifice is delayed to the 19th day. The sustained action of Ca-DTPA in the skeleton, as compared to Zn-DTPA, deserves further studies as it could reveal possible differences in the effectiveness of both chelates.
Our data indicate that the effectiveness of the chelates in the liver cannot be a suitable criterion for their effectiveness in the other soft tissue organs. Following treatment, the decrease of the isotopes tested in spleen, kidneys and endocrine glands is rather similar to that in the skeleton. This is of some interest because in the beagle a higher concentration of 241Am has been reported in the thyroid than in the skeleton, (25) Bearing in mind the above mentioned lower toxicity of Zn=DTPA, outresults encourage further studies re1ating to the question of whether Zn-DTPA could replace Ca-DTPA in the treatment of internal contamination with transuranium elements. These studies should be extended, preferably, to chronic treatment, because the possib1e gain in the therapeutic index of Zn-DTPA, as compared to Ca DTPA, is expected to be especially high in this respect. (10) 
